Everspin Technologies (MRAM) Is Up 17.7% After $40M Navy MRAM Subcontract And Narrower Q1 Loss - Has The Bull Case Changed?

Everspin Technologies, Inc.

Everspin Technologies, Inc.

MRAM

0.00

  • In April 2026, Everspin Technologies announced a US$40,000,000, 30‑month subcontract with Amentum Services under a U.S. Navy microelectronics RDT&E program, alongside first‑quarter 2026 results showing higher revenue and a smaller net loss than a year earlier.
  • The deal ties Everspin’s Toggle MRAM process technology directly into U.S. defense supply chains, reinforcing its role as an on‑shore memory partner for critical systems.
  • Next, we’ll examine how this US$40,000,000 defense-focused Toggle MRAM subcontract could reshape Everspin’s investment narrative and long-term contract profile.

Invest in the nuclear renaissance through our list of 91 elite nuclear energy infrastructure plays powering the global AI revolution.

Everspin Technologies Investment Narrative Recap

To own Everspin, you need to believe MRAM can carve out a durable niche in mission critical memory while the company improves profitability. The new US$40,000,000 Amentum defense subcontract reinforces near term revenue visibility and ties directly into the key catalyst of government and aerospace contracts, but it also sharpens the existing risk that Everspin remains reliant on a handful of large, discretionary defense and industrial programs.

The most relevant recent update alongside this contract is Everspin’s Q1 2026 report and Q2 guidance, which frame how the subcontract sits against mid teens quarterly revenue and a guided GAAP loss. Together, the earnings trend and the defense deal highlight a tension between growing top line opportunities and the ongoing risk that margins and profitability lag if execution or contract timing do not break in Everspin’s favor.

Yet investors should be aware that contract dependence can quickly become a problem if funding, timing, or renewals change...

Everspin Technologies' narrative projects $90.9 million revenue and $7.9 million earnings by 2029. This requires 16.9% yearly revenue growth and about a $7.6 million earnings increase from $284.0 thousand today.

Uncover how Everspin Technologies' forecasts yield a $18.00 fair value, a 16% downside to its current price.

Exploring Other Perspectives

MRAM 1-Year Stock Price Chart
MRAM 1-Year Stock Price Chart

Before this news, the most optimistic analysts were counting on MRAM design wins converting into US$70.2 million of revenue and US$11.3 million of earnings by 2029, so if you are weighing this new defense contract you should recognize that these higher targets reflect a much more optimistic view than the consensus and could shift again as the story evolves.

Explore 2 other fair value estimates on Everspin Technologies - why the stock might be worth 16% less than the current price!

Decide For Yourself

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

  • A great starting point for your Everspin Technologies research is our analysis highlighting 2 key rewards and 2 important warning signs that could impact your investment decision.
  • Our free Everspin Technologies research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Everspin Technologies' overall financial health at a glance.

Want Some Alternatives?

Opportunities like this don't last. These are today's most promising picks. Check them out now:

  • AI is about to change healthcare. These 35 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
  • Outshine the giants: these 16 early-stage AI stocks could fund your retirement.
  • We've uncovered the 12 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.